[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-who-owns-edwards-lifesciences-top-shareholders-and-recent-insider-trades-ES":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":193,"suggestedPosts":269},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},87648,"¿A quién pertenece Edwards Lifesciences? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02T17:44:32","2026-01-02T17:44:34","\u003Cp>A continuación se indica quiénes tienen las mayores participaciones en Edwards Lifesciences en la actualidad y qué sugieren las recientes actividades de propiedad y de información privilegiada sobre el crecimiento a largo plazo y la demanda cardiaca estructural.\u003C\u002Fp>\n","\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=411220&tid=2608553&ref=srk6m3\">\u003Cstrong>Edwards Lifesciences Corporation (NYSE: EW)\u003C\u002Fstrong>\u003C\u002Fa> es una empresa líder en tecnología médica centrada en las cardiopatías estructurales y la monitorización de cuidados críticos. Las acciones cotizaban recientemente en torno a \u003Cstrong> 84 dólares por título\u003C\u002Fstrong>, lo que supone una capitalización bursátil de unos \u003Cstrong> 49.500 millones de dólares\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Edwards Lifesciences opera en mercados cardiovasculares altamente especializados, donde los volúmenes de procedimientos, los ciclos de innovación y las tendencias de gasto hospitalario desempeñan un papel significativo en el rendimiento a largo plazo. Observar quién posee Edwards Lifesciences y las últimas operaciones con información privilegiada ayuda a mostrar el posicionamiento actual de los grandes inversores.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Descubra cuánto podrían subir sus acciones favoritas utilizando el nuevo modelo de valoración de TIKR (es gratuito) >>>.\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-who-are-edwards-lifesciences-top-shareholders\">\u003Cstrong>\u003Cstrong>¿Quiénes son los principales accionistas de Edwards Lifesciences?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1481\" height=\"866\" data-public-id=\"images\u002FEW-.2\u002FEW-.2.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1481,h_866,c_scale\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA\" alt=\"Edwards Lifesciences stock\" class=\"wp-post-87648 wp-image-87690\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1767373402\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA 1481w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_175,c_scale\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_599,c_scale\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_449,c_scale\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_702,c_scale\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_819,c_scale\u002Ff_webp,q_auto\u002Fv1767373402\u002Fimages\u002FEW-.2\u002FEW-.2.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1481px) 100vw, 1481px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Principales accionistas de Edwards Lifesciences\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>La base accionarial de Edwards Lifesciences está encabezada por importantes instituciones pasivas. Estas empresas tienden a mantenerse a lo largo de los ciclos del mercado, lo que puede ayudar a mantener estable la propiedad a largo plazo. Los gestores activos ajustaron en ambas direcciones, apuntando a una mezcla de convicción y disciplina de valoración.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>The Vanguard Group\u003C\u002Fstrong>: 70,09 millones de acciones (12,08%), \u003Cstrong> valor de ~6.000 millones de dólares\u003C\u002Fstrong>. Añadió 359.015 acciones (+0,51%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>BlackRock Institutional Trust Company\u003C\u002Fstrong>: 30,52 millones de acciones (5,26%), \u003Cstrong>~2.600 millones de dólares de valor\u003C\u002Fstrong>. Recorta 370.162 acciones (1,20%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>State Street Investment Management\u003C\u002Fstrong>: 25,62 millones de acciones (4,41%), \u003Cstrong> por un valor aproximado de 2.200 millones de dólares\u003C\u002Fstrong>. Recorta 14.746 acciones (0,06%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Wellington Management Company\u003C\u002Fstrong>: 20,80 millones de acciones (3,59%), \u003Cstrong> valor aproximado de 1.800 millones de dólares\u003C\u002Fstrong>. Ha añadido 977.933 acciones (+4,93%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>J.P. Morgan Asset Management\u003C\u002Fstrong>: 17,92 millones de acciones (3,09%), \u003Cstrong>~1.500 millones de dólares de valor\u003C\u002Fstrong>. Recorta 2,17 millones de acciones (10,80%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Jennison Associates\u003C\u002Fstrong>: 13,96 millones de acciones (2,41%), \u003Cstrong> valor aproximado de 1.200 millones de dólares\u003C\u002Fstrong>. Añade 2,29 millones de acciones (+19,60%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fidelity Management & Research\u003C\u002Fstrong>: 13,03 millones de acciones (2,25%), \u003Cstrong> valor aproximado de 1.100 millones de dólares\u003C\u002Fstrong>. Añadidas 10,73 millones de acciones (+466,56%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Geode Capital Management\u003C\u002Fstrong>: 12,84 millones de acciones (2,21%), \u003Cstrong> valor aproximado de 1.100 millones de dólares\u003C\u002Fstrong>. Añadidas 114.729 acciones (+0,90%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Walter Scott & Partners\u003C\u002Fstrong>: 9,96 millones de acciones (1,72%), \u003Cstrong> valor aproximado de 849 millones de dólares\u003C\u002Fstrong>. Incorporación de 1,05 millones de acciones (+11,73%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Union Investment Privatfonds GmbH\u003C\u002Fstrong>: 8,60 millones de acciones (1,48%), \u003Cstrong> por\u003C\u002Fstrong> un \u003Cstrong> valor de ~734 millones de dólares\u003C\u002Fstrong>. Añadidas 19.169 acciones (+0,22%).\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>La presencia de grandes tenedores pasivos proporciona una base de propiedad estable, mientras que las compras y recortes selectivos entre los gestores activos sugieren que los inversores están sopesando de cerca la valoración y la ejecución. Para los inversores, esta combinación de propiedad indica un compromiso institucional continuado sin un cambio de consenso claro.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\" id=\"h-hedge-fund-highlights\">Fondos de cobertura destacados\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>Squarepoint Ops LLC\u003C\u002Fstrong>, fundada por \u003Cstrong>Guilherme Schmid\u003C\u002Fstrong>, aumentó su posición en Edwards Lifesciences en torno a \u003Cstrong>un 228%\u003C\u002Fstrong>, lo que eleva su participación a un \u003Cstrong> valor\u003C\u002Fstrong> aproximado de \u003Cstrong> 17,7 millones de dólares\u003C\u002Fstrong>. El movimiento podría reflejar el creciente optimismo en torno a los volúmenes de procedimientos cardíacos estructurales.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Jane Street Group\u003C\u002Fstrong>, cofundado por \u003Cstrong>Rob Granieri\u003C\u002Fstrong>, aumentó sus participaciones en torno a \u003Cstrong>un 183%\u003C\u002Fstrong> y ahora posee aproximadamente \u003Cstrong> 121 millones de dólares\u003C\u002Fstrong> en acciones de Edwards Lifesciences, lo que la convierte en una de las mayores posiciones activas de fondos de cobertura.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Kingdon Capital Management\u003C\u002Fstrong>, dirigido por su fundador \u003Cstrong>Mark Kingdon\u003C\u002Fstrong>, aumentó su participación en torno a \u003Cstrong>un 175%\u003C\u002Fstrong>, hasta un \u003Cstrong> valor\u003C\u002Fstrong> aproximado de \u003Cstrong> 19,6 millones de dólares\u003C\u002Fstrong>, un incremento notable tras la reciente volatilidad de la cotización.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Schonfeld Strategic Advisors\u003C\u002Fstrong>, fundada por \u003Cstrong>Steven Schonfeld\u003C\u002Fstrong>, elevó su posición en torno a \u003Cstrong>un 77%\u003C\u002Fstrong>, hasta un valor aproximado de \u003Cstrong> 16,8 millones de dólares\u003C\u002Fstrong>. Para los inversores, la actividad de los hedge funds parece selectivamente constructiva, aunque el posicionamiento sigue siendo diversificado más que concentrado.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Siga a los principales accionistas de más de 50.000 valores mundiales (es gratis) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-edwards-lifesciences-recent-insider-trades\">\u003Cstrong>\u003Cstrong>Últimas operaciones de Edwards Lifesciences con información privilegiada\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1476\" height=\"872\" data-public-id=\"images\u002FEW-.3\u002FEW-.3.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1476,h_872,c_scale\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA\" alt=\"Edwards Lifesciences stock\" class=\"wp-post-87648 wp-image-87691\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1767373410\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA 1476w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_177,c_scale\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_605,c_scale\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_454,c_scale\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_709,c_scale\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_827,c_scale\u002Ff_webp,q_auto\u002Fv1767373410\u002Fimages\u002FEW-.3\u002FEW-.3.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1476px) 100vw, 1476px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Últimas operaciones con información privilegiada de Edwards Lifesciences\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Las operaciones con información privilegiada pueden ofrecer un contexto sobre cómo los ejecutivos pueden estar gestionando la exposición personal, aunque no reflejan necesariamente opiniones sobre el rendimiento a corto plazo. Los archivos recientes de Edwards Lifesciences muestran en su mayoría pequeñas transacciones que se inclinan hacia la venta.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Wayne Markowitz (directivo)\u003C\u002Fstrong>: Vendió 650 acciones a ~77,57 dólares.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Andrew M. Dahl (directivo)\u003C\u002Fstrong>: Vendió 262 acciones a ~77,57 dólares.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Daveen Chopra (directivo)\u003C\u002Fstrong>: Vendió 2.500 acciones a ~81,95 dólares; registró acciones a 0 dólares.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Larry L. Wood (antiguo directivo)\u003C\u002Fstrong>: Vendió múltiples bloques de 8.950 acciones; registró acciones a 0 $.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Daniel J. Lippis (directivo)\u003C\u002Fstrong>: Vendió 4.114 acciones a ~79,46 dólares y 333 acciones a ~76,79 dólares.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Annette Bruls (directiva)\u003C\u002Fstrong>: Vendió 109 acciones a ~78,80 dólares.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>Varios archivos muestran acciones registradas a 0 $, que parecen vinculadas a adjudicaciones de acciones o entradas administrativas más que a compras en el mercado abierto. Para los inversores, la actividad con información privilegiada parece comedida y no cambia significativamente la dinámica general de la propiedad.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Consulte los datos recientes sobre operaciones con información privilegiada de más de 50.000 valores de todo el mundo (es gratis) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-ownership-amp-insider-trade-data-tell-us\">Qué nos dicen los datos sobre propiedad y operaciones con información privilegiada\u003C\u002Fh2>\n\n\n\n\u003Cp>Edwards Lifesciences sigue anclada en inversores institucionales a largo plazo, con fondos pasivos que aportan estabilidad y gestores activos que mantienen el compromiso mediante adiciones y recortes selectivos. El posicionamiento de los fondos de cobertura es cautelosamente positivo, mientras que la actividad de la información privilegiada sigue siendo modesta.\u003C\u002Fp>\n\n\n\n\u003Cp>Para los inversores, los datos sugieren que Edwards Lifesciences sigue considerándose una empresa de tecnología médica de alta calidad, aunque los inversores parecen estar sopesando el potencial de crecimiento a largo plazo frente a los riesgos de valoración y ejecución.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-value-any-stock-in-under-60-seconds-it-s-free\">\u003Cstrong>\u003Cstrong>\u003Cstrong>Valore cualquier acción en menos de 60 segundos (es gratis)\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Con la \u003Cstrong>nueva herramienta Valuation Model\u003C\u002Fstrong> de TIKR, puede estimar el precio potencial de una acción en menos de un minuto.\u003C\u002Fp>\n\n\n\n\u003Cp>Todo lo que necesita son tres simples datos:\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Crecimiento de los ingresos\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Márgenes operativos\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Múltiplo PER de salida\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>A partir de ahí, TIKR calcula el precio potencial de la acción y la rentabilidad total en los \u003Cstrong>escenarios\u003C\u002Fstrong> \u003Cstrong>alcista, bajista y básico\u003C\u002Fstrong>, para que pueda ver rápidamente si una acción parece \u003Cstrong>infravalorada o sobrevalorada\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Si no está seguro de qué introducir, TIKR rellena automáticamente cada entrada utilizando las estimaciones de consenso de los analistas, ofreciéndole un punto de partida rápido y fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Vea el valor real de una acción en menos de 60 segundos (gratis con TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n",845,"es","\u002Fblog\u002Fwho-owns-edwards-lifesciences-top-shareholders-and-recent-insider-trades","who-owns-edwards-lifesciences-top-shareholders-and-recent-insider-trades","images\u002FEdwards-Lifesciences-stock_87692d9b10\u002FEdwards-Lifesciences-stock_87692d9b10","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767375348\u002Fimages\u002FEdwards-Lifesciences-stock_87692d9b10\u002FEdwards-Lifesciences-stock_87692d9b10.png?_i=AA",{"altText":165,"imageCredit":166},"Who Owns Edwards Lifesciences? Top Shareholders and Recent Insider Trades","@LAONG from LAONG via Canva",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Nikko Henson","nikkotikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"Thomas Richmond","thomastikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"Reseñas de Acciones","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"Here’s who holds the biggest stakes in Edwards Lifesciences today and what recent ownership and insider activity suggest about long term growth and structural heart demand.",{"title":165,"description":186,"twitterTitle":165,"twitterDescription":186,"author":168,"articlePublisher":188,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":189,"twitterData1":190,"ogTitle":165,"ogDescription":186,"ogUrl":160,"ogImage":163,"ogImageWidth":191,"ogImageHeight":192,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"TIKR.com","Tiempo de lectura estimado","6 minutes",1200,630,[194,209,224,239,254],{"id":183,"title":195,"date":196,"excerpt":197,"wordCount":198,"uri":199,"slug":200,"cloudinaryAssetId":201,"featuredImageOriginalUrl":202,"featuredImageMetadata":203,"author":204,"categories":206,"relatedPosts":208},"¿A quién pertenece Dexcom? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 12:35:00","A continuación, le mostramos quién posee las mayores participaciones en Dexcom en la actualidad y qué sugieren las recientes tendencias de propiedad y de información privilegiada sobre la confianza en las perspectivas de crecimiento a largo plazo de la empresa.",932,"\u002Fblog\u002Fwho-owns-dexcom-top-shareholders-and-recent-insider-trades","who-owns-dexcom-top-shareholders-and-recent-insider-trades","images\u002FDexCom-stock_8766759841\u002FDexCom-stock_8766759841","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767355202\u002Fimages\u002FDexCom-stock_8766759841\u002FDexCom-stock_8766759841.png?_i=AA",{"altText":195},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":205},[],[207],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":210,"date":211,"excerpt":212,"wordCount":213,"uri":214,"slug":215,"cloudinaryAssetId":216,"featuredImageOriginalUrl":217,"featuredImageMetadata":218,"author":219,"categories":221,"relatedPosts":223},"¿A quién pertenece DaVita? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 12:05:00","A continuación se muestra quién tiene las mayores participaciones en DaVita en la actualidad y qué sugieren los recientes movimientos de los propietarios, los fondos de cobertura y la información privilegiada sobre la confianza en el flujo de caja a largo plazo de la empresa y la demanda de asistencia sanitaria.",897,"\u002Fblog\u002Fwho-owns-davita-top-shareholders-and-recent-insider-trades","who-owns-davita-top-shareholders-and-recent-insider-trades","images\u002FDaVita-stock_87652924ea\u002FDaVita-stock_87652924ea","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767341997\u002Fimages\u002FDaVita-stock_87652924ea\u002FDaVita-stock_87652924ea.png?_i=AA",{"altText":210},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":220},[],[222],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":225,"date":226,"excerpt":227,"wordCount":228,"uri":229,"slug":230,"cloudinaryAssetId":231,"featuredImageOriginalUrl":232,"featuredImageMetadata":233,"author":234,"categories":236,"relatedPosts":238},"¿A quién pertenece Cardinal Health? Principales accionistas y últimas operaciones con información privilegiada","2026-01-01 20:46:35","A continuación se muestra quién tiene las mayores participaciones en Cardinal Health en la actualidad y qué sugieren los recientes cambios en la propiedad y la actividad de información privilegiada sobre la confianza en la recuperación de los beneficios de la empresa y la demanda defensiva de atención sanitaria.",808,"\u002Fblog\u002Fwho-owns-cardinal-health-top-shareholders-and-recent-insider-trades","who-owns-cardinal-health-top-shareholders-and-recent-insider-trades","images\u002FCardinal-Health-stock\u002FCardinal-Health-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767300193\u002Fimages\u002FCardinal-Health-stock\u002FCardinal-Health-stock.png?_i=AA",{"altText":225},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":235},[],[237],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":240,"date":241,"excerpt":242,"wordCount":243,"uri":244,"slug":245,"cloudinaryAssetId":246,"featuredImageOriginalUrl":247,"featuredImageMetadata":248,"author":249,"categories":251,"relatedPosts":253},"¿A quién pertenece Boston Scientific Corporation? Principales accionistas y últimas operaciones con información privilegiada","2026-01-01 18:26:00","A continuación se muestra quién tiene las mayores participaciones en Boston Scientific en la actualidad y qué sugieren los recientes cambios en la propiedad y la actividad de información privilegiada sobre la confianza en las perspectivas de crecimiento a largo plazo de la empresa.",815,"\u002Fblog\u002Fwho-owns-boston-scientific-corporation-top-shareholders-and-recent-insider-trades","who-owns-boston-scientific-corporation-top-shareholders-and-recent-insider-trades","images\u002FBoston-Scientific-stock_876227d911\u002FBoston-Scientific-stock_876227d911","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767291606\u002Fimages\u002FBoston-Scientific-stock_876227d911\u002FBoston-Scientific-stock_876227d911.png?_i=AA",{"altText":240},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":250},[],[252],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":255,"date":256,"excerpt":257,"wordCount":258,"uri":259,"slug":260,"cloudinaryAssetId":261,"featuredImageOriginalUrl":262,"featuredImageMetadata":263,"author":264,"categories":266,"relatedPosts":268},"¿A quién pertenece Bio-Techne Corporation? Principales accionistas y últimas operaciones con información privilegiada","2026-01-01 13:35:00","A continuación se indica quiénes tienen las mayores participaciones en Bio-Techne Corporation en la actualidad y qué sugieren los recientes cambios en la propiedad y la actividad de información privilegiada sobre la confianza en el crecimiento a largo plazo de la empresa y la demanda de ciencias de la vida.",872,"\u002Fblog\u002Fwho-owns-bio-techne-corporation-top-shareholders-and-recent-insider-trades","who-owns-bio-techne-corporation-top-shareholders-and-recent-insider-trades","images\u002FBio-Techne-stock\u002FBio-Techne-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767269654\u002Fimages\u002FBio-Techne-stock\u002FBio-Techne-stock.png?_i=AA",{"altText":255},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":265},[],[267],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[270,289,304,319,334,349,369,384,399,416],{"id":183,"title":271,"date":272,"excerpt":273,"wordCount":274,"uri":275,"slug":276,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":277,"featuredImageMetadata":278,"author":279,"categories":283,"relatedPosts":288},"Por qué las acciones de Broadcom (AVGO) subieron un 50% en 2025","2026-01-02 14:45:00","Broadcom (AVGO), que ha caído un 15% desde sus máximos históricos, es un valor tecnológico de gran capitalización que ha devuelto un 50% a sus accionistas en 2025. ",656,"\u002Fblog\u002Fwhy-broadcom-nasdaq-avgo-stock-rose-50-in-2025","why-broadcom-nasdaq-avgo-stock-rose-50-in-2025","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F01\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-8-600x400.png",{"altText":271},{"name":280,"slug":281,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":282},"Aditya Raghunath","adityatikr",[],[284],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},"Inversión General","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":183,"title":290,"date":291,"excerpt":292,"wordCount":293,"uri":294,"slug":295,"cloudinaryAssetId":296,"featuredImageOriginalUrl":297,"featuredImageMetadata":298,"author":299,"categories":301,"relatedPosts":303},"Por qué las acciones de Kratos Defense subieron un 190% en 2025","2026-01-02 14:15:00","Las acciones de Kratos Defense casi triplicaron el patrimonio de los inversores el año pasado, ya que la empresa de seguridad sigue ampliando su foso competitivo. ",1160,"\u002Fblog\u002Fwhy-kratos-defense-nasdaq-ktos-stock-surged-190-in-2025","why-kratos-defense-nasdaq-ktos-stock-surged-190-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767361825\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7.png?_i=AA",{"altText":290},{"name":280,"slug":281,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":300},[],[302],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},[],{"id":183,"title":305,"date":306,"excerpt":307,"wordCount":308,"uri":309,"slug":310,"cloudinaryAssetId":311,"featuredImageOriginalUrl":312,"featuredImageMetadata":313,"author":314,"categories":316,"relatedPosts":318},"Por qué las acciones de Dollar Tree subieron un 64% en 2025","2026-01-02 13:45:00","Las acciones de Dollar Tree subieron un 64% en 2025, aplastando los rendimientos del mercado en general, ya que el minorista de descuento se centró en sus esfuerzos de reconversión. ",966,"\u002Fblog\u002Fwhy-dollar-tree-nasdaq-dltr-stock-rose-64-in-2025","why-dollar-tree-nasdaq-dltr-stock-rose-64-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767360245\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956.png?_i=AA",{"altText":305},{"name":280,"slug":281,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":315},[],[317],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},[],{"id":183,"title":320,"date":321,"excerpt":322,"wordCount":323,"uri":324,"slug":325,"cloudinaryAssetId":326,"featuredImageOriginalUrl":327,"featuredImageMetadata":328,"author":329,"categories":331,"relatedPosts":333},"Por qué las acciones de Nebius subieron un 200% en 2025","2026-01-02 12:00:00","Las acciones de Nebius, que han caído un 40% desde sus máximos históricos, se han triplicado con creces en 2025 a medida que ganan terreno en el mercado de la IA, en rápida expansión. ",888,"\u002Fblog\u002Fwhy-nebius-nasdaq-nbis-stock-rose-200-in-2025","why-nebius-nasdaq-nbis-stock-rose-200-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767353835\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87.png?_i=AA",{"altText":320},{"name":280,"slug":281,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":330},[],[332],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},[],{"id":183,"title":335,"date":336,"excerpt":337,"wordCount":338,"uri":339,"slug":340,"cloudinaryAssetId":341,"featuredImageOriginalUrl":342,"featuredImageMetadata":343,"author":344,"categories":346,"relatedPosts":348},"Por qué las acciones de Asana cayeron un 32% en 2025","2026-01-02 11:15:00","Con una caída de más del 90% desde sus máximos históricos, las acciones de Asana siguieron registrando un rendimiento inferior al de los mercados más amplios en 2025. ",731,"\u002Fblog\u002Fwhy-asana-stock-fell-32-in-2025","why-asana-stock-fell-32-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767351571\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98.png?_i=AA",{"altText":335},{"name":280,"slug":281,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":345},[],[347],{"name":285,"slug":286,"uri":287,"description":171,"postsCount":183},[],{"id":183,"title":350,"date":351,"excerpt":352,"wordCount":353,"uri":354,"slug":355,"cloudinaryAssetId":356,"featuredImageOriginalUrl":357,"featuredImageMetadata":358,"author":359,"categories":363,"relatedPosts":368},"CaixaBank acaba de alcanzar máximos históricos. Podrá seguir subiendo en 2026?","2025-12-31 15:15:00","A pesar de un repunte masivo, nuestro modelo muestra que las acciones de CABK podrían rendir alrededor de un 15% hasta 2030 a medida que su negocio de seguros se dispare.",987,"\u002Fblog\u002Fcaixabank-just-hit-all-time-highs-can-the-stock-keep-climbing-in-2026","caixabank-just-hit-all-time-highs-can-the-stock-keep-climbing-in-2026","images\u002F2_873969caee\u002F2_873969caee","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767053079\u002Fimages\u002F2_873969caee\u002F2_873969caee.png?_i=AA",{"altText":350},{"name":360,"slug":361,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":362},"Wiltone Asuncion","wiltonetikr",[],[364],{"name":365,"slug":366,"uri":367,"description":171,"postsCount":183},"Valoración","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":183,"title":370,"date":371,"excerpt":372,"wordCount":373,"uri":374,"slug":375,"cloudinaryAssetId":376,"featuredImageOriginalUrl":377,"featuredImageMetadata":378,"author":379,"categories":381,"relatedPosts":383},"Las acciones del Banco Bilbao Vizcaya Argentaria (BBVA) han subido un 110% este año, ¿todavía tienen recorrido?","2025-12-31 14:30:00","A pesar de unos márgenes operativos de primera clase, nuestro modelo prevé una rentabilidad anualizada del -1,2% para las acciones de BBVA en los próximos dos años.",1095,"\u002Fblog\u002Fup-110-this-year-does-banco-bilbao-vizcaya-argentaria-bbva-stock-still-have-room-to-run","up-110-this-year-does-banco-bilbao-vizcaya-argentaria-bbva-stock-still-have-room-to-run","images\u002FCopy-of-Random-Featured-Image-1-1\u002FCopy-of-Random-Featured-Image-1-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1766137070\u002Fimages\u002FCopy-of-Random-Featured-Image-1-1\u002FCopy-of-Random-Featured-Image-1-1.png?_i=AA",{"altText":370},{"name":360,"slug":361,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":380},[],[382],{"name":365,"slug":366,"uri":367,"description":171,"postsCount":183},[],{"id":183,"title":385,"date":386,"excerpt":387,"wordCount":388,"uri":389,"slug":390,"cloudinaryAssetId":391,"featuredImageOriginalUrl":392,"featuredImageMetadata":393,"author":394,"categories":396,"relatedPosts":398},"Las acciones del Banco de Sabadell han subido un 300% en los últimos 3 años, ¿podrán continuar su racha en 2026?","2025-12-30 16:15:00","Esta es la razón por la que las acciones de Banco Sabadell han subido un 87% desde sus mínimos de 52 semanas. Las acciones de Banco Sabadell podrían alcanzar su precio objetivo de 3,58 euros en 2029. ",1088,"\u002Fblog\u002Fup-300-over-the-past-3-years-can-banco-de-sabadell-stock-continue-its-run-in-2026","up-300-over-the-past-3-years-can-banco-de-sabadell-stock-continue-its-run-in-2026","images\u002FCopy-of-Random-Featured-Image-2\u002FCopy-of-Random-Featured-Image-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1766141023\u002Fimages\u002FCopy-of-Random-Featured-Image-2\u002FCopy-of-Random-Featured-Image-2.png?_i=AA",{"altText":385},{"name":360,"slug":361,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":395},[],[397],{"name":365,"slug":366,"uri":367,"description":171,"postsCount":183},[],{"id":183,"title":400,"date":401,"excerpt":402,"wordCount":403,"uri":404,"slug":405,"cloudinaryAssetId":406,"featuredImageOriginalUrl":407,"featuredImageMetadata":408,"author":409,"categories":413,"relatedPosts":415},"Por qué Netflix podría superar los 131 dólares por acción y alcanzar máximos históricos en 2026","2025-12-30 15:45:00","Netflix podría ofrecer una rentabilidad superior al 30% en 2027, ya que el crecimiento constante de los ingresos, la expansión de los márgenes y unas hipótesis de valoración estables respaldan el alza impulsada por los beneficios.",1212,"\u002Fblog\u002Fheres-why-netflix-could-pass-131-share-and-potentially-reach-all-time-highs-in-2026","heres-why-netflix-could-pass-131-share-and-potentially-reach-all-time-highs-in-2026","images\u002FFEATURED-IMAGE-MAKER-3_86684d6804\u002FFEATURED-IMAGE-MAKER-3_86684d6804","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1765994506\u002Fimages\u002FFEATURED-IMAGE-MAKER-3_86684d6804\u002FFEATURED-IMAGE-MAKER-3_86684d6804.png?_i=AA",{"altText":400},{"name":410,"slug":411,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":412},"Gian Estrada","giantikr",[],[414],{"name":365,"slug":366,"uri":367,"description":171,"postsCount":183},[],{"id":183,"title":417,"date":418,"excerpt":419,"wordCount":420,"uri":421,"slug":422,"cloudinaryAssetId":423,"featuredImageOriginalUrl":424,"featuredImageMetadata":425,"author":426,"categories":428,"relatedPosts":430},"Por qué este valor de mediana capitalización podría subir un 100% en los próximos dos años","2025-12-30 12:30:00","dLocal es un valor de crecimiento de mediana capitalización que cotiza con una valoración atractiva dadas sus estimaciones estelares de ingresos y beneficios. ",1121,"\u002Fblog\u002Fwhy-this-mid-cap-nasdaq-dlo-stock-could-surge-100-over-the-next-two-years","why-this-mid-cap-nasdaq-dlo-stock-could-surge-100-over-the-next-two-years","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767093096\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1.png?_i=AA",{"altText":417},{"name":280,"slug":281,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":427},[],[429],{"name":365,"slug":366,"uri":367,"description":171,"postsCount":183},[]]